Swedish Orphan Biovitrum AB
SOBI · OMXSTO · SEK
SEK 433.80
−7.40 −1.68%todayNot financial advice.
- Open
- 439.80
- Day range
- 431.60 - 441.80
- 52-week range
- 304.80 - 487.00
- Volume
- 86.43K
- Market cap
- 15.24B
- P/E ratio
- 112.68
- EPS
- 0.41
- Dividend yield
- 0.00%
- Beta
- 0.71
Performance
W
+1.45%
1M
−1.81%
3M
−3.98%
6M
+5.19%
YTD
+29.49%
Y
+43.17%
5Y
+93.42%
All
+1,221.67%
In the news
Oct 16
Sobi Wins Positive CHMP Opinion to Expand TRYNGOLZA Use in Europe
Sobi earned a positive CHMP opinion to expand TRYNGOLZA in Europe for severe hypertriglyceridemia, with a final decision expected in Q4 2026.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/OMXSTO-SOBI" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Swedish Orphan Biovitrum AB (SOBI) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/OMXSTO-SOBI">SOBI stock price</a> by FreeTheAI Stocks</p>